Digital Therapeutics - DTx
Digital Therapeutics are a new therapeutic class
In comparison to traditional drugs and biologics , DTx:
- are used directly or indirectly to treat serious diseases
- are developed, deployed and built under Good Automated Manufacturing Practices
- have demonstrated safety and efficacy (SISPQ) through randomised clinical trials
- receive labeled claims from EMA and FDA
- are prescribed by physician
- are reimbursed as products through government and healthcare insurers
3.life is an innovator in this new sector and has built a pipeline of digital therapeutic applications across multiple therapeutic areas.
Digital Medicine
Digital Health products have become integral to:
- the prevention,
- diagnosis,
- treatment,
- management of health and disease.
Digital Medicine includes evidence-based software and/or hardware products that measure and/or intervene in the service of human health.
3.life_DTx
Digital therapeutics innovator
3.life pushes the boundaries of data integration, technology and artificial intelligence, to transform into connected, personalised medicine and therapy. By developing and delivering clinically tested and validated AI-driven software therapeutics.
Increasing the quality of life, through better therapy engagement and behavioral change. Supported by smart tracking tools for all parties involved; resulting in cost-effective solutions for all.
3.life has built a pipeline of digital therapeutic applications across multiple therapeutic areas. With a main focus on mental health diagnoses, which have a significant impact on the quality of life.
